LD-2 disclosure · 1st Quarter - Termination
LUMINOPIA, INC.
Coverage · No income or expenses were reported on this filing.
Client
- Name
- LUMINOPIA, INC.
- Description
- Digital therapeutics company.
- Location
- Massachusetts · United States of America
Registrant
- Description
- Consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics.
LobbyistsJOHN KEVIN BRENNAN
TargetedSENATE · HOUSE OF REPRESENTATIVES